I agree Our site saves small pieces of text information (cookies) on your device in order to deliver better content and for statistical purposes. You can disable the usage of cookies by changing the settings of your browser. By browsing our website without changing the browser settings you grant us permission to store that information on your device.
Methyl Pyruvate acts as a potent secretagogue used in the study of stimulus-secretion coupling. Also used in the preparation of quinoxalines as dual phoosphodiesterase 2/10 (PDE2/10) inhibitors. It increases free calcium ion concentration in the cytosol of pancreatic cells. It is used in the preparation of dimethyl 2,3-dimethylenebutanedioate.
G. Bond, P.A. Meheux; A. Ibbotson; P.B. Wells. Origin of enhanced rate in the platinum-catalysed enantioselective hydrogenation of methyl pyruvate. Catalysis Today. 1991, 10 (3), 371-378.
I.M. Sutherland; A. Ibbotson; R.B. Moyes; P.B. Wells. Enantioselective hydrogenation I. Surface conditions during methyl pyruvate hydrogenation catalyzed by cinchonidine-modified platinum/silica (EUROPT-1). Journal of Catalysis. 1990, 125 (1), 77-88.
Hazard Statements: H226
Flammable liquid and vapour.
Precautionary Statements: P260-P201-P280-P304+P340-P405-P501a
Do not breathe dust/fume/gas/mist/vapours/spray. Obtain special instructions before use. Wear protective gloves/protective clothing/eye protection/face protection. IF INHALED: Remove to fresh air and keep at rest in a position comfortable for breathing. Store locked up. Dispose of contents/container in accordance with local/regional/national/international regulations.